Cargando…
Cord blood cell-derived iPSCs as a new candidate for chondrogenic differentiation and cartilage regeneration
BACKGROUND: The native articular cartilage lacks the ability to heal. Currently, ex vivo expanded chondrocytes or bone marrow-derived mesenchymal stem cells are used to regenerate the damaged cartilage. With unlimited self-renewal ability and multipotency, human induced pluripotent stem cells (hiPSC...
Autores principales: | Nam, Yoojun, Rim, Yeri Alice, Jung, Seung Min, Ju, Ji Hyeon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5273802/ https://www.ncbi.nlm.nih.gov/pubmed/28129782 http://dx.doi.org/10.1186/s13287-017-0477-6 |
Ejemplares similares
-
Application of Cord Blood and Cord Blood-Derived Induced Pluripotent Stem
Cells for Cartilage Regeneration
por: Rim, Yeri Alice, et al.
Publicado: (2018) -
Current Therapeutic Strategies for Stem Cell-Based Cartilage Regeneration
por: Nam, Yoojun, et al.
Publicado: (2018) -
Chondrogenic Differentiation from Induced Pluripotent Stem Cells Using Non-Viral Minicircle Vectors
por: Rim, Yeri Alice, et al.
Publicado: (2020) -
Different Chondrogenic Potential among Human Induced Pluripotent Stem Cells from Diverse Origin Primary Cells
por: Rim, Yeri Alice, et al.
Publicado: (2018) -
Modeling cartilage pathology in mucopolysaccharidosis VI using iPSCs reveals early dysregulation of chondrogenic and metabolic gene expression
por: Broeders, M., et al.
Publicado: (2022)